Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 7


Results: 38
    1
    2
    3
    4
    5
    6

    Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID‐19 Outbreak.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1013, doi. 10.1634/theoncologist.2020-0316
    By:
    • Viale, Giulia;
    • Licata, Luca;
    • Sica, Lorenzo;
    • Zambelli, Stefania;
    • Zucchinelli, Patrizia;
    • Rognone, Alessia;
    • Aldrighetti, Daniela;
    • Di Micco, Rosa;
    • Zuber, Veronica;
    • Pasetti, Marcella;
    • Di Muzio, Nadia;
    • Rodighiero, Mariagrazia;
    • Panizza, Pietro;
    • Sassi, Isabella;
    • Petrella, Giovanna;
    • Cascinu, Stefano;
    • Gentilini, Oreste Davide;
    • Bianchini, Giampaolo
    Publication type:
    Article
    7
    8
    9

    Opioids for Breakthrough Cancer Pain.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1133, doi. 10.1634/theoncologist.2020-0280
    By:
    • Currow, David C.;
    • Clark, Katherine
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Oncology in 2050 – A Retrospective?

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1127, doi. 10.1634/theoncologist.2019-0887
    By:
    • Joshua, Anthony M.;
    • Tannock, Ian F.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. e1070, doi. 10.1634/theoncologist.2019-0976
    By:
    • Tzogani, Kyriaki;
    • Røshol, Hilde;
    • Olsen, Helga Haugom;
    • Aas, Ida B.;
    • Dalhus, Marianne Løiten;
    • Håkonsen, Gro Dahlseng;
    • Nilssen, Laila Sortvik;
    • Lindberg, Vibeke;
    • Økvist, Mats;
    • Bolstad, Bjørg;
    • Rogovska, Irēna;
    • Karpova, Natalja;
    • Enzmann, Harald;
    • Gisselbrecht, Christian;
    • Pignatti, Francesco
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.‐Based Neuroendocrine Tumor Cohort.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. 572, doi. 10.1634/theoncologist.2019-0743
    By:
    • Heckert, Jason M.;
    • Kipnis, Sarit T.;
    • Kumar, Shria;
    • Botterbusch, Samuel;
    • Alderson, Alice;
    • Bennett, Bonita;
    • Creamer, Caroline;
    • Eads, Jennifer R.;
    • Soulen, Michael C.;
    • Pryma, Daniel A.;
    • Mankoff, David A.;
    • Metz, David C.;
    • Katona, Bryson W.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.

    Published in:
    Oncologist, 2020, v. 25, n. 7, p. 560, doi. 10.1634/theoncologist.2019-0932
    By:
    • Collins, Julie M.;
    • Donahue, Renee N.;
    • Tsai, Yo‐Ting;
    • Manu, Michell;
    • Palena, Claudia;
    • Gatti‐Mays, Margaret E.;
    • Marté, Jennifer L.;
    • Madan, Ravi A.;
    • Karzai, Fatima;
    • Heery, Christopher R.;
    • Strauss, Julius;
    • Abdul‐Sater, Houssein;
    • Cordes, Lisa;
    • Schlom, Jeffrey;
    • Gulley, James L.;
    • Bilusic, Marijo
    Publication type:
    Article